| Literature DB >> 34448089 |
Jianli Li1, Saixian Ma2, Xiujie Chang2, Songxu Ju2, Meng Zhang2, Dongdong Yu2, Junfang Rong2.
Abstract
The study aimed to investigate the efficacy of PCV-VG combined with individual PEEP during laparoscopic surgery in the Trendelenburg position. 120 patients were randomly divided into four groups: VF group (VCV plus 5cmH2O PEEP), PF group (PCV-VG plus 5cmH2O PEEP), VI group (VCV plus individual PEEP), and PI group (PCV-VG plus individual PEEP). Pmean, Ppeak, Cdyn, PaO2/FiO2, VD/VT, A-aDO2 and Qs/Qt were recorded at T1 (15 min after the induction of anesthesia), T2 (60 min after pneumoperitoneum), and T3 (5 min at the end of anesthesia). The CC16 and IL-6 were measured at T1 and T3. Our results showed that the Pmean was increased in VI and PI group, and the Ppeak was lower in PI group at T2. At T2 and T3, the Cdyn of PI group was higher than that in other groups, and PaO2/FiO2 was increased in PI group compared with VF and VI group. At T2 and T3, A-aDO2 of PI and PF group was reduced than that in other groups. The Qs/Qt was decreased in PI group compared with VF and VI group at T2 and T3. At T2, VD/VT in PI group was decreased than other groups. At T3, the concentration of CC16 in PI group was lower compared with other groups, and IL-6 level of PI group was decreased than that in VF and VI group. In conclusion, the patients who underwent laparoscopic surgery, PCV-VG combined with individual PEEP produced favorable lung mechanics and oxygenation, and thus reducing inflammatory response and lung injury.Clinical Trial registry: chictr.org. identifier: ChiCTR-2100044928.Entities:
Keywords: Individualized PEEP; Laparoscopic surgery; Lung protection; Pressure-controlled ventilation-volume guaranteed mode; Trendelenburg position
Mesh:
Substances:
Year: 2021 PMID: 34448089 PMCID: PMC9293798 DOI: 10.1007/s10877-021-00750-9
Source DB: PubMed Journal: J Clin Monit Comput ISSN: 1387-1307 Impact factor: 1.977
Fig. 1Study protocol of the incremental PEEP titration procedure directed by Cdyn in patients of the VI and PI group
Fig. 2The study protocol
Demographic Characteristics
| Index | VF (n=30) | PF (n=30) | VI (n=30) | PI (n=30) |
|---|---|---|---|---|
| Age(years) | 45.0 ± 14.3 | 43.9 ± 13.8 | 48.8 ± 15.6 | 48.9 ± 13.5 |
| Sex(F/M) | 25/5 | 26/4 | 25/5 | 25/5 |
| Height(cm) | 162.9 ± 6.8 | 163.3 ± 7.4 | 162.2 ± 6.9 | 162.0 ± 6.8 |
| BMI (kg/m2) | 24.8 ± 3.6 | 24.6 ± 3.1 | 24.7 ± 3.9 | 25.0 ± 3.0 |
| PBW (kg) | 55.1 ± 6.3 | 55.1 ± 6.0 | 54.5 ± 6.4 | 54.3 ± 6.3 |
| ASA(I/II/III) | 0/29/1 | 0/28/2 | 0/27/3 | 0/28/2 |
Data are presented as mean ± standard deviation or number of patients; ASA: American Society of Anesthesiologists, BMI: body mass index, F:female, M: male, PBW: estimated weight; VF: VCV plus fixed PEEP of 5cmH2O, PF: PCV-VG plus fixed PEEP of 5cmH2O, VI: VCV plus individual PEEP, PI: PCV-VG plus individual PEEP
Intraoperative Data
| Index | VF (n = 30) | PF (n = 30) | VI (n = 30) | PI(n = 30) |
|---|---|---|---|---|
| Type of surgery | ||||
| Gastrointestinal Surgery | 8(26.7%) | 9(30.0%) | 7(23.3%) | 8(26.7%) |
| Gynecology | 22(73.3%) | 21(70.0%) | 23(76.7%) | 22(73.3%) |
| Vasoactive drugs | 9(30.0%) | 10(33.3%) | 8(26.7%) | 11(36.7%) |
| Volume of fluid (mL) | 1000(1000,1100) | 1000(1000,1500) | 1000(1000,1500) | 1000(1000,1500) |
| Urine output (mL) | 100(50,200) | 100(50,200) | 100(50,150) | 100(50,100) |
| Duration of operation (min) | 82(70,103) | 81(75,107) | 95(76,106) | 95(90,105) |
Duration of anesthesia (min) | 112(87,135) | 114(100,141) | 130(105,155) | 130(110,140) |
| Duration of pneumoperitoneum (min) | 68(60,90) | 70(65,93) | 85(65,100) | 85(79,100) |
| Blood loss (mL) | 15(5,23) | 20(10,50) | 20(10,80) | 30(9,50) |
| HR (bpm) | ||||
| T1 | 66.0 ± 9.3 | 66.3 ± 11.2 | 67.1 ± 7.7 | 65.8 ± 6.2 |
| T2 | 75.6 ± 10.9 | 73.6 ± 7.2 | 74.6 ± 4.6 | 75.0 ± 7.0 |
| T3 | 69.2 ± 9.6 | 67.7 ± 9.0 | 67.5 ± 5.1 | 67.6 ± 6.3 |
| MAP (mmHg) | ||||
| T1 | 88.8 ± 12.4 | 82.9 ± 18.1 | 82.1 ± 14.5 | 85.3 ± 11.7 |
| T2 | 96.6 ± 17.7 | 94.9 ± 13.4 | 95.5 ± 13.5 | 94.6 ± 15.1 |
| T3 | 87.8 ± 16.6 | 89.5 ± 14.1 | 87.0 ± 11.5 | 87.4 ± 10.6 |
Data are expressed as mean ± standard deviation (SD) or median (interquartile range).VF: VCV plus fixed PEEP of 5cmH2O, PF:PCV-VG plus fixed PEEP of 5cmH2O, VI:VCV plus individual PEEP, PI:PCV-VG plus individual PEEP.T1:in the supine position 15 min after the induction of anesthesia, T2:60 min after CO2 pneumoperitoneum and Trendelenburg position, T3: 5 min after placement in the supine position at the end of anesthesia
Respiratory mechanics, Ventilatory and Oxygenation parameters
| Index | Time | VF | PF | VI | PI |
|---|---|---|---|---|---|
VT (mL) | T1 | 386 ± 44 | 386 ± 42 | 382 ± 45 | 383 ± 43 |
| T2 | 384 ± 44 | 384 ± 42 | 381 ± 45 | 381 ± 44 | |
| T3 | 389 ± 43 | 384 ± 42 | 382 ± 43 | 378 ± 44 | |
PEEP (cmH2O) | T1 | 5 | 5 | 6(4,8) ▲△ | 6(4,8) ▲△ |
| T2 | 5 | 5 | 8(6,10) ▲△ | 8(6,10) ▲△ | |
| T3 | 5 | 5 | 6(4,8)▲△ | 6(4,8) ▲△ | |
(cmH2O) | T1 | 15.4 ± 1.9 | 15.5 ± 2.3 | 15.9 ± 1.9 | 15.2 ± 3.2 |
| T2 | 24.1 ± 2.4 | 23.4 ± 2.3 | 24.9 ± 2.5△ | 21.9 ± 2.5▲△ | |
| T3 | 15.6 ± 2.4 | 15.2 ± 2.7 | 17.8 ± 2.4▲△ | 15.1 ± 2.9 | |
(cmH2O) | T1 | 11.0 ± 3.2 | 10.0 ± 2.2 | 10.1 ± 3.4 | 9.8 ± 2.4 |
| T2 | 13.1 ± 2.2 | 13.9 ± 2.9 | 16.5 ± 2.9▲△ | 16.8 ± 2.2▲△ 20▲△ | |
| T3 | 10.8 ± 1.6 | 11.6 ± 2.3 | 10.0 ± 2.0△ | 9.4 ± 2.4▲△ | |
Cdyn (mL/cmH2O) | T1 | 49.8 ± 8.7 | 51.2 ± 8.8 | 54.5 ± 9.9 | 59.7 ± 16.3▲△ |
| T2 | 25.5 ± 3.7 | 27.4 ± 4.6 | 29.0 ± 5.0 | 33.7 ± 7.1▲△* | |
| T3 | 34.3 ± 3.8 | 42.1 ± 7.0▲ | 43.6 ± 8.0▲ | 53.2 ± 13.1▲△* | |
PaO2/FiO2 (mmHg) | T1 | 374 ± 16 | 378 ± 31 | 378 ± 18 | 379 ± 23 |
| T2 | 278 ± 28 | 332 ± 39▲ | 298 ± 35▲△ | 338 ± 25▲* | |
| T3 | 286 ± 31 | 326 ± 14▲ | 289 ± 30△ | 341 ± 16▲△* | |
| T1 | 0.36 ± 0.03 | 0.36 ± 0.03 | 0.37 ± 0.02 | 0.37 ± 0.02 | |
| T2 | 0.46 ± 0.03 | 0.43 ± 0.02▲ | 0.44 ± 0.02▲ | 0.34 ± 0.05▲△* | |
| T3 | 0.35 ± 0.03 | 0.35 ± 0.03 | 0.36 ± 0.02 | 0.36 ± 0.07 | |
| Qs/Qt | T1 | 0.12(0.12,0.13) | 0.12(0.11,0.13) | 0.12(0.12,0.13) | 0.12(0.11,0.13) |
| T2 | 0.16(0.15,0.16) | 0.14(0.13,0.16)▲ | 0.15(0.14,0.16)▲△ | 0.13(0.13,0.14)▲* | |
| T3 | 0.15(0.15,0.16) | 0.14(0.13,0.14)▲ | 0.15(0.15,0.16)△ | 0.13(0.13,0.14)▲△* | |
A-aDO2 (mmHg) | T1 | 226.8 ± 14.3 | 222.4 ± 26.7 | 224.0 ± 14.8 | 223.5 ± 18.6 |
| T2 | 298.9 ± 21.6 | 255.6 ± 32.3▲ | 282.8 ± 28.1▲△ | 250.9 ± 20.0▲ | |
| T3 | 291.5 ± 24.5 | 260.0 ± 13.3▲ | 289.1 ± 22.9△ | 248.1 ± 13.9▲△* |
Data are expressed as mean ± standard deviation (SD) or median (interquartile range). VF: VCV plus fixed PEEP of 5cmH2O, PF: PCV-VG plus fixed PEEP of 5cmH2O, VI: VCV plus individual PEEP, PI: PCV-VG plus individual PEEP.T1: in the supine position 15 min after the induction of anesthesia, T2: 60 min after CO2 pneumoperitoneum and Trendelenburg position, T3: 5 min after placement in the supine position at the end of anesthesia
Compared with group VF, ▲p < 0.05
Compared with group PF,△p < 0.05
Compared with group VI, *p < 0.05
Blood gas analysis
| Index | Time | VF | PF | VI | PI |
|---|---|---|---|---|---|
| T1 | 7.39 ± 0.04 | 7.39 ± 0.03 | 7.39 ± 0.02 | 7.39 ± 0.02 | |
| pH | T2 | 7.38 ± 0.04 | 7.38 ± 0.04 | 7.39 ± 0.03 | 7.39 ± 0.03 |
| T3 | 7.38 ± 0.04 | 7.38 ± 0.04 | 7.39 ± 0.02 | 7.39 ± 0.04 | |
PaCO2 (mmHg) | T1 | 35.4 ± 3.0 | 36.5 ± 4.1 | 35.4 ± 4.0 | 35.1 ± 1.9 |
| T2 | 39.5 ± 4.1 | 39.4 ± 4.0 | 39.2 ± 1.9 | 39.1 ± 2.3 | |
| T3 | 40.3 ± 2.9 | 40.0 ± 2.6 | 39.9 ± 2.9 | 39.4 ± 3.3 | |
PaO2 (mmHg) | T1 | 299 ± 13 | 302 ± 24 | 302 ± 14 | 303 ± 18 |
| T2 | 222 ± 22 | 266 ± 31▲ | 239 ± 28▲△ | 271 ± 20▲* | |
| T3 | 229 ± 25 | 260 ± 12▲ | 232 ± 24△ | 273 ± 13▲△* |
Data are expressed as mean ± standard deviation (SD) or median (interquartile range). VF: VCV plus fixed PEEP of 5cmH2O, PF: PCV-VG plus fixed PEEP of 5cmH2O, VI: VCV plus individual PEEP, PI: PCV-VG plus individual PEEP.T1: in the supine position 15 min after the induction of anesthesia, T2: 60 min after CO2 pneumoperitoneum and Trendelenburg position, T3: 5 min after placement in the supine position at the end of anesthesia
Compared with group VF, ▲p < 0.05
Compared with group PF,△p < 0.05
Compared with group VI, *p < 0.05
Serum CC16 and IL-6 concentrations (ng/ml)
| Index | Time | VF (n = 30) | PF (n = 30) | VI (n = 30) | PI (n = 30) |
|---|---|---|---|---|---|
| CC16 | T1 | 5.0 ± 1.2 | 4.9 ± 1.2 | 5.0 ± 1.3 | 5.0 ± 1.4 |
| T3 | 60.6 ± 11.5 | 53.4 ± 11.1 | 53.0 ± 11.0 | 47.1 ± 11.9 | |
| IL-6 | T1 | 13.5(5.3,58.6) | 10.6(4.6,57.5) | 10.9(5.3,58.0) | 10.0(4.5,57.4) |
| T3 | 66.0 ± 17.4 | 52.2 ± 18.3 | 62.2 ± 17.1 | 46.0 ± 23.8 |
Data are expressed as mean ± standard deviation (SD) or median (interquartile range). VF: VCV plus fixed PEEP of 5cmH2O, PF: PCV-VG plus fixed PEEP of 5cmH2O, VI: VCV plus individual PEEP, PI: PCV-VG plus individual PEEP.T1: in the supine position 15 min after the induction of anesthesia, T3: 5 min after placement in the supine position at the end of anesthesia
Compared with group VF, ▲p < 0.05
Compared with group PF, △p < 0.05
Compared with group VI, *p < 0.05
Postoperative outcomes
| Index | VF (n = 30) | PF (n = 30) | VI (n = 30) | PI (n = 30) |
|---|---|---|---|---|
| WBC (× 109) | 6.2 ± 1.5 | 5.8 ± 1.1 | 5.7 ± 1.4 | 6.0 ± 1.2 |
| neutrophile (× 109) | 5.1 ± 1.5 | 4.8 ± 0.9 | 4.7 ± 1.2 | 4.7 ± 1.6 |
| cough | 0(0%) | 0(0%) | 2(7%) | 0(0%) |
| expectoration | 1(3%) | 1(3%) | 0(0%) | 0(0%) |
| fever | 1(3%) | 1(3%) | 0(0%) | 0(0%) |
Data are expressed as mean ± standard deviation (SD) or median (interquartile range). VF: VCV plus fixed PEEP of 5cmH2O, PF: PCV-VG plus fixed PEEP of 5cmH2O, VI: VCV plus individual PEEP, PI: PCV-VG plus individual PEEP